Comment: parenteral H2-receptor antagonist intervention.
Glazier
H S
HS
D003362:Cost-Benefit Analysis; D006635:Histamine H2 Antagonists / Q000008:administration & dosage*; D006801:Humans; D007263:Infusions, Parenteral / Q000191:economics*; D015397:Program Evaluation
D006635:Histamine H2 Antagonists